InVivo Therapeutics is focused on developing and commercializing technologies for the treatment of spinal cord injuries (SCI). The company’s aim is to develop/commercialize biocompatible polymer scaffolding devices to treat acute spinal cord injuries; biocompatible hydrogel to treat acute spinal cord injuries and peripheral nerve injuries; and biocompatible polymer scaffolding devices seeded with autologous human neural stem cells to treat acute and chronic spinal cord injuries. For further information, visit the company’s Web site at www.invivotherapeutics.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: